TG THERAPEUTICS, INC. (TGTX) Net margin 2016–2025
TG THERAPEUTICS, INC. (TGTX) net profit margin by fiscal year — reported net income divided by reported revenue.
72.6%FY2025 · since FY2016: -51482.2% → 72.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 72.6% | +65.5 pp |
| FY2024 | 7.1% | +1.7 pp |
| FY2023 | 5.4% | +8041.8 pp |
| FY2022 | -8036.3% | -2832.3 pp |
| FY2021 | -5204.1% | +178599.2 pp |
| FY2020 | -183803.3% | -70072.4 pp |
| FY2019 | -113730.9% | +402.0 pp |
| FY2018 | -114132.9% | -36188.2 pp |
| FY2017 | -77944.7% | -26462.5 pp |
| FY2016 | -51482.2% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More TGTX financial trends
TGTX RevenueTGTX Net incomeTGTX Gross profitTGTX Gross marginTGTX Operating incomeTGTX Operating marginTGTX Operating cash flowTGTX Free cash flowTGTX Capital expendituresTGTX Return on equityTGTX Stock buybacksTGTX Dividends paidTGTX Total assetsTGTX Total liabilitiesTGTX Shareholders’ equityTGTX overview →